Records containing: Pleomorphic Xanthoastrocytoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-24A Phase II Study of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
-
CLINICAL_TRIALS study record update · 2026-04-02An Open Label, Multi-center Roll-over Study to Assess Long-term Effect in Pediatric Patients Treated With Tafinlar (Dabrafenib) and/or Mekinist (Trametinib)
-
CLINICAL_TRIALS study record update · 2026-03-04Comprehensive Analysis of Chemotherapy and Targeted Therapy Outcomes in Recurrent Malignant Gliomas: Large Single-Center Observational Cohort Study (GLIOTARG)
-
CLINICAL_TRIALS study record update · 2025-12-18A First-in-human Phase I Single-agent Dose-escalation, Food Effect and Dose Expansion Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
-
CLINICAL_TRIALS study record update · 2025-08-08A Randomized and Controlled Phase II Protocol in Non NF1 Pediatric and AYA (Adolescent and Young Adults) Patients Bearing a Newly Diagnosed Low Grade Glioma With Wild Type BRAF Gene Comparing a Daily Oral MEK Inhibitor (Trametinib) Versus Weekly Vinblastine for 18 Months
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-07-05A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
-
CLINICAL_TRIALS study record update · 2023-12-14Defining Personal and Communal Aspects of Social Determinants of Health in Glioblastoma Population
-
CLINICAL_TRIALS study record update · 2023-05-19Phase II Open-label Global Study to Evaluate the Effect of Dabrafenib in Combination With Trametinib in Children and Adolescent Patients With BRAF V600 Mutation Positive Low Grade Glioma (LGG) or Relapsed or Refractory High Grade Glioma (HGG)